1. Home
  2. IMRN vs SKK Comparison

IMRN vs SKK Comparison

Compare IMRN & SKK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRN
  • SKK
  • Stock Information
  • Founded
  • IMRN 1994
  • SKK 2013
  • Country
  • IMRN Australia
  • SKK Singapore
  • Employees
  • IMRN N/A
  • SKK N/A
  • Industry
  • IMRN Biotechnology: Pharmaceutical Preparations
  • SKK
  • Sector
  • IMRN Health Care
  • SKK
  • Exchange
  • IMRN Nasdaq
  • SKK NYSE
  • Market Cap
  • IMRN 10.3M
  • SKK 12.3M
  • IPO Year
  • IMRN N/A
  • SKK 2024
  • Fundamental
  • Price
  • IMRN $1.71
  • SKK $0.74
  • Analyst Decision
  • IMRN Strong Buy
  • SKK
  • Analyst Count
  • IMRN 1
  • SKK 0
  • Target Price
  • IMRN $5.00
  • SKK N/A
  • AVG Volume (30 Days)
  • IMRN 11.8K
  • SKK 76.7K
  • Earning Date
  • IMRN 05-27-2025
  • SKK 02-14-2025
  • Dividend Yield
  • IMRN N/A
  • SKK N/A
  • EPS Growth
  • IMRN N/A
  • SKK N/A
  • EPS
  • IMRN N/A
  • SKK N/A
  • Revenue
  • IMRN $4,048,286.00
  • SKK $8,631,000.00
  • Revenue This Year
  • IMRN N/A
  • SKK N/A
  • Revenue Next Year
  • IMRN N/A
  • SKK N/A
  • P/E Ratio
  • IMRN N/A
  • SKK N/A
  • Revenue Growth
  • IMRN 82.90
  • SKK N/A
  • 52 Week Low
  • IMRN $1.60
  • SKK $0.61
  • 52 Week High
  • IMRN $2.87
  • SKK $11.45
  • Technical
  • Relative Strength Index (RSI)
  • IMRN 41.94
  • SKK N/A
  • Support Level
  • IMRN $1.87
  • SKK N/A
  • Resistance Level
  • IMRN $2.13
  • SKK N/A
  • Average True Range (ATR)
  • IMRN 0.15
  • SKK 0.00
  • MACD
  • IMRN -0.01
  • SKK 0.00
  • Stochastic Oscillator
  • IMRN 32.71
  • SKK 0.00

About IMRN Immuron Limited

Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.

About SKK SKK HOLDINGS LIMITED

SKK Holdings Ltd is a civil engineering service provider that specializes in subsurface utility works in Singapore. It construct and maintain various public works and infrastructure projects that serve the society and the environment. Its projects are primarily the subsurface work related to projects undertaken by the Public Utilities Board (PUB) and Singapore Telecommunications Limited. The nature of these projects is related to repairing of pumping mains, sewer maintenance and pipe cable laying.

Share on Social Networks: